GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NuGen Medical Devices Inc (TSXV:NGMD) » Definitions » Debt-to-Asset

NuGen Medical Devices (TSXV:NGMD) Debt-to-Asset : 1.29 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is NuGen Medical Devices Debt-to-Asset?

NuGen Medical Devices's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was C$2.21 Mil. NuGen Medical Devices's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was C$5.94 Mil. NuGen Medical Devices's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2024 was C$6.30 Mil. NuGen Medical Devices's debt to asset for the quarter that ended in Mar. 2024 was 1.29.


NuGen Medical Devices Debt-to-Asset Historical Data

The historical data trend for NuGen Medical Devices's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NuGen Medical Devices Debt-to-Asset Chart

NuGen Medical Devices Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Debt-to-Asset
0.49 0.67 1.08 1.14

NuGen Medical Devices Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.08 0.99 0.87 1.14 1.29

Competitive Comparison of NuGen Medical Devices's Debt-to-Asset

For the Medical Devices subindustry, NuGen Medical Devices's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NuGen Medical Devices's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, NuGen Medical Devices's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where NuGen Medical Devices's Debt-to-Asset falls into.



NuGen Medical Devices Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

NuGen Medical Devices's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

NuGen Medical Devices's Debt-to-Asset for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NuGen Medical Devices  (TSXV:NGMD) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


NuGen Medical Devices Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of NuGen Medical Devices's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


NuGen Medical Devices (TSXV:NGMD) Business Description

Traded in Other Exchanges
Address
18 King Street East, Suite 1400, Toronto, ON, CAN, M5C 1C4
NuGen Medical Devices Inc is a medical device manufacturing company specializing in the field of needleless injections and related technologies. The reportable segment of the company is the manufacturing of needless injector devices. Geographically the company generates revenue from Asia, Europe and others.
Executives
Richard Buzbuzian Director, Senior Officer

NuGen Medical Devices (TSXV:NGMD) Headlines

No Headlines